The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants

Transplantation

Volumn 53, Issue 2, 1992, Pages 323-328

  Gulanikar, Avinash C ^a,b   Macdonald, Allan S ^a,b   Sungurtekin, Ugur ^a,b   Belitsky, Philip ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Department of Urology ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CREATINE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; PREDNISONE;

ACUTE DISEASE; ADULT; CADAVER KIDNEY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL RATE;

ADULT; CADAVER; CYCLOSPORINE; DRUG RESISTANCE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMAN; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGE; PREDNISONE; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0026607659     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199202010-00013     Document Type: Article

References (23)

1. Terasaki P, Mickey MR, Cecka M, Iwaki Y, Ciciarelli J. Clinical kidney transplants, 1988. Immunol Lett 1988; 21: 33.
2. Opelz G for the Collaborative Transplant Study. Comparison of immunosuppressive protocols in renal transplantation: a multi-center view. Transplant Proc 1988; 20: 31.
3. Ackerman JR, deFor WM, Kahan L, et al. Prophylactic use of OKT3 in renal transplantation: part of a prospective randomized trial. Transplant Proc 1988; 20: 242.
4. Cecka MJ, Terasaki PI. Early rejection episodes. In: Terasaki P, ed. Clinical transplants 1989. Los Angeles: UCLA Tissue Typing Laboratory, 1989: 425.
5. Isoniemi H, Ahonen J, Eklund B, et al. Renal allograft immuno- suppression: a randomized trial of withdrawal of one drug in triple drug immunosuppression. Transplant Int 1990; 3: 121.
6. Brinker KR, Dickerman RM, Gonwa TA, et al. A randomized trial comparing double-drug and triple-drug therapy in primary cadaveric renal transplants. Transplantation 1990; 50: 43.
7. Belitsky P, Gupta R. Minicore needle biopsy of kidney transplants: a safer sampling method. J Urol 1990; 144: 310.
8. Belitsky P, Van Spingelen J, Field C, Gupta R. Development of a nomogram to interpret transplant aspiration cytology findings. Transplant Proc 1989; 20: 694
9. Belitsky P, MacDonald AS, Cohen AD, et al. Comparison of antilymphocyte globulin and continuous IV cyclosporine A as induction immunosuppression for cadaver kidney transplants: A prospective randomized study. Transplant Proc 1991; 23: 999.
10. Restifo AC, Petrie JB, Ridby RJ, et al. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low risk, first cadaver renal allograft recipients. Transplant Proc 1989; 21: 1604.
11. DeVecchi A, Tarantino A, Mantagnino G, et al. A controlled prospective trial of triple therapy with low dose azathioprine, cyclosporine and methylprednisone in renal transplantation. Transplant Proc 1987; 19:1933.
12. Slapak M, Geoghegan T, Digard N, Ahmed K, Sharman VL, Crockett R. The use of low dose cyclosporine in combination with azathioprine and steroids in renal transplantation. Transplant Proc 1985; 17: 1222.
13. Fries D, Hiesse C, Charpentier B, et al. Triple combination of low dose cyclosporine, azathioprine and steroids in first cadaver donor renal allografts. Transplant Proc 1987; 19:1911.
14. Hardy MA, Nowygrad R, Elbey A, Appel G. Use of ATG in treatment of steroid resistant rejection. Transplantation 1980; 29: 162.
15. Hiesse C, Fries D, Charpentier B, et al. Optimal results in cadaver renal transplantation using prophylactic ALG, cyclosporine and prednisone. Transplant Proc 1987; 19: 3670.
16. Stratta RJ, D'Alessandro AM, Armbrust MJ, et al. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol. Transplant Proc 1988; 21:1726.
17. Bauma WD, Tang IYS, Maddux MS, Veremis SA, Pollack R, Mozes MF. Delayed graft function following cadaver renal transplantation in the cyclosporine era—analysis of acute rejection and graft survival. Transplant Proc 1989; 121: 1276.
18. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocom- patibility complex antigen expression in ischemic acute tubular necrosis in the mouse kidney. Transplantation 1990; 49: 201.
19. Swinner LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990; 323: 1723.
20. Cosimi AB, Rubin RH. Post transplantation lymphoproliferative disorder and OKT3. N Engl J Med 1991; 324: 1438.
21. Richardson AJ, Higgins RM, Liddington H, Murrie J, Ting A, Morris PJ. Antithymocyte globulin for steroid resistant rejection in renal transplant recipients immunosuppressed with triple therapy. Transplant Int 1989; 2: 27.
22. Rocher LL, Hodgson RJ, Merion RM, et al. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine. Transplantation 1989; 47: 249.
23. Gulanikar AC, Belitsky P, MacDonald AS, Cohen A, Bitter-Suer-mann H. Randomized controlled trial of steroids versus no ster-iods in stable cyclosporine treated renal graft recipients. Transplant Proc 1991; 23: 990.